Which scenario does not give coronary artery bypass grafting (CABG) an advantage over percutaneous coronary intervention (PCI): left main disease, two‑vessel disease including proximal left anterior descending artery, three‑vessel disease with left ventricular dysfunction, or three‑vessel disease with ST‑segment elevation myocardial infarction and cardiogenic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

CABG Does Not Have an Advantage Over PCI in Three-Vessel Disease with STEMI and Cardiogenic Shock

The answer is D: 3-vessel disease with STEMI and cardiogenic shock is the scenario where CABG does NOT have an advantage over PCI.

Rationale Based on Guidelines

The ACC/AHA guidelines consistently demonstrate clear CABG superiority for options A, B, and C, but option D represents a unique emergency scenario where PCI is actually preferred:

Option A - Left Main Disease: CABG Has Clear Advantage

  • CABG receives Class I recommendation for unprotected left main disease 1, 2, 3
  • PCI is only Class IIa (reasonable alternative) in highly selected cases with low SYNTAX scores (<22) and high surgical risk 1, 2
  • For stable patients with unfavorable anatomy, PCI is Class III: Harm versus CABG 1, 2

Option B - Two-Vessel Disease Including Proximal LAD: CABG Has Clear Advantage

  • CABG receives Class I recommendation for 2-vessel disease with proximal LAD involvement 1, 2, 3
  • PCI is only Class IIb (uncertain benefit) in this anatomic setting 1, 2
  • The proximal LAD involvement specifically favors CABG for survival benefit

Option C - Three-Vessel Disease with LV Dysfunction: CABG Has Clear Advantage

  • CABG receives Class IIa recommendation for LV dysfunction with EF 35-50% 1, 2
  • CABG receives Class IIb recommendation even for severe LV dysfunction (EF <35%) without significant left main disease 1, 2
  • PCI has "insufficient data" for LV dysfunction scenarios 1, 2
  • The combination of 3-vessel disease and LV dysfunction strongly favors surgical revascularization

Option D - Three-Vessel Disease with STEMI and Cardiogenic Shock: PCI is Preferred

This is the critical exception where CABG loses its advantage:

  • In STEMI with cardiogenic shock, multivessel PCI of the culprit vessel is preferred over complete revascularization 4
  • The CULPRIT-SHOCK trial demonstrated that complete multivessel PCI in cardiogenic shock was associated with WORSE outcomes compared to culprit-only PCI 4
  • For left main STEMI specifically, guidelines state: "IIa—For STEMI when distal coronary flow is TIMI flow grade <3 and PCI can be performed more rapidly and safely than CABG" 1, 2, 3

Key Clinical Reasoning

The fundamental principle: In cardiogenic shock with STEMI, time to reperfusion is paramount and trumps the usual anatomic considerations that favor CABG. The physiologic instability and need for immediate revascularization make emergency CABG prohibitively risky.

Why CABG Loses Its Advantage in Shock:

  1. Hemodynamic instability makes the patient a poor surgical candidate
  2. Time to reperfusion is critical - PCI can be performed immediately while CABG requires preparation
  3. Surgical risk is dramatically elevated in cardiogenic shock
  4. Complete revascularization in shock is harmful - culprit-only strategy is preferred 4

Common Pitfall to Avoid:

Do not extrapolate the benefits of CABG for stable multivessel disease to the emergency setting of STEMI with cardiogenic shock. The evidence clearly shows that attempting complete revascularization (whether by PCI or CABG) in cardiogenic shock worsens outcomes 4. The priority shifts from anatomic completeness to rapid restoration of flow in the culprit vessel.

In contrast, for stable patients with 3-vessel disease (without acute STEMI and shock), CABG maintains its Class I recommendation with Class IIa support for choosing CABG over PCI when SYNTAX score >22 1, 2, 3.

Related Questions

What are the mechanisms and procedural steps of coronary artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI)?
When should percutaneous coronary intervention (PCI) be chosen instead of coronary artery bypass grafting (CABG) for coronary artery disease?
Can you give a concrete example illustrating DRG assignment and payment calculation for a 68-year-old male with hypertension and type 2 diabetes who undergoes percutaneous coronary intervention for an acute ST‑segment elevation myocardial infarction, including the impact of a major complication and potential outlier payment?
Does a 50% stenosis in the left main coronary artery (LMCA) and a 50% stenosis in the right coronary artery (RCA) constitute multi-vessel coronary artery disease?
Is Wellens' syndrome considered an ST-elevation myocardial infarction (STEMI) equivalent?
Does metformin lower or raise cortisol levels?
Which oral anticoagulant should be given instead of enoxaparin (Clexane) 40 mg once daily?
What are the causes of altered perception of one's own voice due to hearing changes?
What torsemide dose and dosing frequency should replace furosemide (Lasix) 20 mg twice daily in an adult with normal renal function and no contraindications to loop diuretics?
Should trastuzumab (herceptin) be administered to a patient with a left ventricular ejection fraction of 57% and grade 2 diastolic dysfunction?
What are the alternative names (generic and brand) for hyoscine (hyoscyamine) and dicyclomine (Bentyl)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.